Combined CD137 (4-1BB) and adjuvant therapy generates a developing pool of peptide-specific CD8 memory T cells.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  International Immunology

• Publication date

  2006-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/INTIMM/DXH371PMID 16373363
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression and function of 4‐1BB during CD4 versus CD8 T cell responses in vivo

  2004cited by this paper
• A Switch in Costimulation from CD28 to 4-1BB during Primary versus Secondary CD8 T Cell Response to Influenza In Vivo1

  2004cited by this paper
• Impaired antigen-induced CD8+ T cell clonal expansion in aging is due to defects in antigen presenting cell function.

  2004cited by this paper
• Toll-Like Receptor Ligands Directly Promote Activated CD4+ T Cell Survival

  2004cited by this paper
• Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

  2003cited by this paper
• Expression of CD137 (4‐1BB) on Human Follicular Dendritic Cells

  2003cited by this paper
• 4–1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity

  2002cited by this paper
• Cutting Edge: Expression of Functional CD137 Receptor by Dendritic Cells1

  2002cited by this paper
• In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses

  2002cited by this paper
• Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells.

  2002cited by this paper
• Temporal Segregation of 4-1BB Versus CD28-Mediated Costimulation: 4-1BB Ligand Influences T Cell Numbers Late in the Primary Response and Regulates the Size of the T Cell Memory Response Following Influenza Infection1

  2002cited by this paper
• Immune Responses in 4-1BB (CD137)-Deficient Mice1

  2002cited by this paper
• Vaccines: Effector and memory T-cell differentiation: implications for vaccine development

  2002cited by this paper
• 4-1BB Ligand Induces Cell Division, Sustains Survival, and Enhances Effector Function of CD4 and CD8 T Cells with Similar Efficacy1

  2001cited by this paper
• Visualizing the generation of memory CD4 T cells in the whole body

  2001cited by this paper
• Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue

  2001cited by this paper
• Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo

  2000cited by this paper
• Cell proliferation and apoptosis in the immune system in the elderly

  2000cited by this paper
• Co‐stimulation of antigen‐specific CD4 T cells by 4‐1BB ligand

  2000cited by this paper
• Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

  1999cited by this paper
• Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal.

  1999cited by this paper
• 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses.

  1999cited by this paper
• NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies.

  1998cited by this paper
• Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.

  1998cited by this paper
• Role of 4-1BB in immune responses.

  1998cited by this paper
• Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals.

  1998cited by this paper
• IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation.

  1998cited by this paper
• OX-40: life beyond the effector T cell stage.

  1998cited by this paper
• 4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses

  1997cited by this paper
• Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

  1997cited by this paper
• Antigen-independent changes in naive CD4 T cells with aging

  1996cited by this paper
• T cell receptor antagonist peptides induce positive selection.

  1994cited by this paper
• Inducible T cell antigen 4-1BB. Analysis of expression and function.

  1993cited by this paper
• cDNA sequences of two inducible T-cell genes.

  1989cited by this paper
• Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors

  1979cited by this paper
• A rapid method for the isolation of functional thymus‐derived murine lymphocytes

  1973cited by this paper

• Delayed reinforcement of costimulation improves the efficacy of mRNA vaccines in mice

  2024cites this paper
• Time-dependent enhancement of mRNA vaccines by 4–1BB costimulation

  2024cites this paper
• Agonism of 4-1BB for immune therapy: a perspective on possibilities and complications

  2023cites this paper
• Evaluating the glycolytic potential of mouse costimulated effector CD8+ T cells ex vivo

  2022cites this paper
• Immunotherapy and Gliomas

  2019cites this paper
• Mechanisms utilized by feline adipose-derived mesenchymal stem cells to inhibit T lymphocyte proliferation

  2019cites this paper
• INHIBITION OF UROTHELIAL CARCINOMA BY TYPE I INTERFERON ACTIVATION OF THE INNATE AND ADAPTIVE IMMUNE RESPONSE

  2019cites this paper
• Understanding how combinatorial targeting of TLRs and TNFR family costimulatory members promote enhanced T cell responses

  2018cites this paper
• Optimal CD4 T cell priming after LPS‐based adjuvanticity with CD134 costimulation relies on CXCL9 production

  2017cites this paper
• CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8+ T Cell–Relevant Genes

  2017cites this paper
• Memory Potential, Molecular Characterization, and Translational Applications of the Novel ThEO/TcEO T Cell Phenotype

  2017cites this paper
• Investigating the Role of Lipopolysaccharide and Polyinosinic:Polycytidylic Acid in Boosting CD4 T cell Responses

  2017cites this paper
• Multimodal imaging analysis of an orthotopic head and neck cancer mouse model and application of anti‐CD137 tumor immune therapy

  2016cites this paper
• This information is current as Established Tumors Antibody Complexes for Control of Immunotherapy with IL-2 / Monoclonal based − Enhancing Dendritic Cell

  2015cites this paper
• T-Cell Costimulation and Its Applications in Diseases

  2015cites this paper
• Enhancing Dendritic Cell–based Immunotherapy with IL-2/Monoclonal Antibody Complexes for Control of Established Tumors

  2015cites this paper
• Responses to LPS boost effector CD8 T-cell accumulation outside of signals 1 and 2

  2015cites this paper
• Manipulation of effector and memory cd8+ T cells via IL-2-antibody complexes

  2015cites this paper
• Novel Technologies for Vaccine Development

  2014cites this paper
• Microenvironment and Immunology SA-4-1 BBL and Monophosphoryl Lipid A Constitute an Ef fi cacious Combination Adjuvant for Cancer Vaccines

  2014cites this paper
• Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant.

  2014cites this paper
• Tumor-Infiltrating Lymphocyte Therapy for Melanoma: Rationale and Issues for Further Clinical Development

  2014cites this paper
• SA-4-1BBL as a platform to develop adjuvant systems for prophylactic and therapeutic vaccines.

  2014cites this paper
• SA-4-1BBL: A Novel Form of the 4-1BB Costimulatory Ligand as an Adjuvant Platform for the Development of Subunit Cancer Vaccines

  2014cites this paper
• SA-4-1BBL and monophosphoryl lipid A constitute an efficacious combination adjuvant for cancer vaccines.

  2014cites this paper
• The contextual role of TNFR family members in CD8+ T‐cell control of viral infections

  2013cites this paper
• Novel antibodies targeting immune regulatory checkpoints for cancer therapy

  2013cites this paper
• Advances in the development of cancer immunotherapies.

  2013cites this paper
• The State of T Cell Immunity against Influenza Virus in Humans and Exploration of Potential Strategies to Enhance Cell-Mediated Protection from Influenza Infection

  2013cites this paper
• Dissecting the Role of 4-1BB and its Ligand in Enhancing CD8 Effector and Memory T Cell Responses

  2012cites this paper
• Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens

  2012cites this paper
• Targeting Spatiotemporal Expression of CD137 on Tumor-infiltrating Cytotoxic T Lymphocytes as a Novel Strategy for Agonistic Antibody Therapy

  2012cites this paper
• Augment CD 8 T Cell Responses during Programmed Death Ligand 1 Blockade To 4-1 BB Signaling Synergizes

  2011cites this paper
• 4-1BB Signaling Synergizes with Programmed Death Ligand 1 Blockade To Augment CD8 T Cell Responses during Chronic Viral Infection

  2011cites this paper
• T‐cell intrinsic effects of GITR and 4‐1BB during viral infection and cancer immunotherapy

  2011cites this paper
• Exploitation of costimulatory SA-4-1BBL in the development of therapeutic cancer vaccines

  2011cites this paper
• Chronic Viral Infection Augment CD8 T Cell Responses during Programmed Death Ligand 1 Blockade To 4-1BB Signaling Synergizes with

  2011cites this paper
• Immunotherapy for Glioblastoma

  2010cites this paper
• Adjuvantive effects of anti-4-1BB agonist Ab and 4-1BBL DNA for a HIV-1 Gag DNA vaccine: different effects on cellular and humoral immunity.

  2010cites this paper
• Involvement of HAb18G/CD147 in T cell activation and immunological synapse formation

  2010cites this paper
• 4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines.

  2010cites this paper
• Evaluating the Cellular Targets of Anti-4-1BB Agonist Antibody during Immunotherapy of a Pre-Established Tumor in Mice

  2010cites this paper
• UPDATE ON VACCINE DEVELOPMENT FOR RENAL CELL CANCER.

  2010cites this paper
• DNA Vaccines against Infectious Diseases and Cancer

  2010cites this paper
• Phenotypic and functional characterization of cytotoxic T lymphocytes in HIV-1 infected South African adults

  2010cites this paper
• Studies on Immunology of Leishmania Mexicana

  2010cites this paper
• DNA Vaccines against Infectious Diseases and Cancer

  2010cites this paper
• Costimulation signals for memory CD8+ T cells during viral infections.

  2009cites this paper
• Cancer immunotherapy: co‐stimulatory agonists and co‐inhibitory antagonists

  2009cites this paper
• ProtEx technology for the generation of novel therapeutic cancer vaccines.

  2009cites this paper
• Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BB ligand eradicates established tumors.

  2009cites this paper
• A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity.

  2009cites this paper
• In vivo depletion of DC impairs the anti‐tumor effect of agonistic anti‐CD137 mAb

  2009cites this paper
• CD137 enhances cytotoxicity of CD3(+)CD56(+) cells and their capacities to induce CD4(+) Th1 responses.

  2009cites this paper
• Combined Triggering of Dendritic Cell Receptors Results in Synergistic Activation and Potent Cytotoxic Immunity1

  2008cites this paper
• Therapeutic Antitumor Efficacy of Anti-CD137 Agonistic Monoclonal Antibody in Mouse Models of Myeloma

  2008cites this paper
• Immunostimulatory monoclonal antibodies for cancer therapy

  2007cites this paper
• CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent1

  2007cites this paper
• Improving vaccines by incorporating immunological coadjuvants

  2007cites this paper
• Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb.

  2007cites this paper
• Dependent Supereffector CD 8 T Cells That Become IL-7 Pathway to Induce Production of CD 134 Costimulation Couples the CD 137

  2007cites this paper
• TGFbeta protein processing and activity through TCR triggering of primary CD8+ T regulatory cells.

  2006cites this paper
• Exploiting 4-1BB Costimulation for Enhancing Antiviral Vaccination

  2006cites this paper
• This information is current as Regulatory Cells T + through TCR Triggering of Primary CD 8 Protein Processing and Activity β TGF

  2006cites this paper
• Immunostimulatory combinations: designing the next generation of vaccine adjuvants

  2006cites this paper
• TGFβ Protein Processing and Activity through TCR Triggering of Primary CD8+ T Regulatory Cells1

  2006cites this paper
• Open Access Journal of Urology Dovepress Update on Vaccine Development for Renal Cell Cancer

  year unknowncites this paper